Successful conversion surgery following tislelizumab with chemotherapy in a patient with stage IIIC lung adenocarcinoma harboring RET fusions: A case report and review of the literature

Experimental and Therapeutic Medicine · 2025 · PMC11843209

Europe PMC

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Despite the small number of patients, those with PD-L1 expression ≥1% showed a trend towards prolonged PFS compared to those with PD-L1 expression <1%.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.